New diabetes drug available

Clinical

New diabetes drug available

In Clinical

Semaglutide (Ozempic), a new once-weekly injectable glucagon-like peptide 1 receptor agonist (GLP-1 RA), is now available for type 2 diabetes.

Semaglutide is used alongside diet and exercise as monotherapy when metformin is inappropriate due to intolerance or contraindications. It can be added to other antidiabetic drugs when type 2 diabetes is insufficiently controlled.

Manufacturer Novo Nordisk remarks that in clinical studies, semaglutide produces superior glycaemic control and weight loss compared with dulaglutide, exenatide once weekly, sitagliptin and insulin glargine U100. Semaglutide offers cardiovascular benefits compared with placebo (added to standard of care) in type 2 diabetes patients at high cardiovascular risk.

Patients begin with 0.25mg once a week for four weeks, followed by 0.5mg once a week. After at least four weeks, the dose can increase to 1.0mg once-weekly if needed. Novo Nordisk says semaglutide “can be prescribed at no additional cost compared to other onceweekly GLP-1 RAs”.

Some preclinical studies associate GLP-1 RAs with an increased risk of thyroid cancer but the latest results are reassuring. “It is important to note that the known class effects of GLP-1 RA on thyroid C-cell hyper- and neoplasia have only been observed in rodents during preclinical animal studies,” Avideh Nazeri, director of clinical, medical and regulatory for Novo Nordisk UK, told Pharmacy Magazine.

“Based on the totality of available data, the human relevance of this effect is considered to be low and in the case of semaglutide is consistent with all other medicines in the class,” Dr Nazeri added. “Across the semaglutide development programme, including more than 4,700 subjects randomised to semaglutide, no medullary thyroid cancers [MTC] were identified.

“However, GLP-1 analogues are contraindicated in people with, or with a history of, MTC. In line with European pharmacovigilance legislation, Novo Nordisk continuously performs ongoing safety surveillance across all of our products, and so surveillance will continue on semaglutide.”

Record my learning outcomes

Clinical

Inspiring stories related to health, fitness and the pursuit of wellbeing

Share:

More like this

bookmark_icon_off
Clinical

Changes benefiting children

NICE has published new draft guidelines that aim to ensure all babies, children and young people using NHS services have the best possible experience of care.

5 Min Article

bookmark_icon_off
Clinical

Briefing: Pharmacy BP checks a lifeline

With stress levels rising, blood pressure screening in community pharmacies is more important than ever.

2 Min Article

bookmark_icon_off
Clinical

Keeping an eye on allergies

Over 21 million people in the UK live with one or more allergic disorders – and it's getting worse.

3 Min Article

bookmark_icon_off
Clinical

Medication madness?

Pharmacists should play a lead role in reducing the harmful effects of opioid use linked to chronic pain.

6 Min Article

bookmark_icon_off
Clinical

Swallowable sponge could reduce need for endoscopies

In trials just one in 30 of the patients offered the Cytosponge were referred for an endoscopy.

1 Min Article

bookmark_icon_off
Clinical

Provide concise advice for pregnant women

Women can feel overwhelmed by all the advice they receive when pregnant or new mothers – so it is important pharmacy is the place to go to for reliable support.

4 Min Article

Recommended Learning

bookmark icon off
Sponsored education

Supporting customers to sleep better

Explore the rotating pack shot to find out more about Nytol Liquid Caramel Flavour, a clinically-proven alternative to sleeping tablets, and understand how you can support customers to sleep better.

5 Min Module

bookmark icon off
Sponsored education

Skincare training for pharmacy

Delve into dry skin management and understand how you can make a difference to customers looking for advice, support and product recommendations to help manage their compromised skin.

15 Min Module

bookmark icon off
Sponsored education

Fungal Nail Roundup

Complete this short interactive module to refresh your knowledge on identifying and treating fungal nail infections, and discover more about a product you can recommend to customers.

5 Min Module

Sponsored education

Constipation: Making effective recommendations

Learn how to help customers with constipation and find out how even brief conversations can have a positive influence on their health.

15 Min Module

bookmark icon off
Sponsored education

Managing hay fever: help meet your customers' needs

This module will improve your hay fever knowledge, helping you to understand its impact on sufferers and recommend the right products to ease symptoms

15 Min Module

Sponsored education

7 steps to tackling children's allergy

Work through this new-style module to increase your confidence in reassuring parents of children with allergies, and know what advice and products to recommend

8 Min Module